Is Bio-Techne Stock a Buy, Sell, or Hold After a Wealth Manager Dumps Its Entire Stake?
2026-03-13 15:09:11 ET
According to a Feb. 17, 2026, SEC filing , Hollow Brook Wealth Management LLC sold out its entire position in Bio-Techne (NASDAQ:TECH) during the fourth quarter of 2025. The fund divested 174,677 shares, with an estimated transaction value of $10.7 million based on the average price for the quarter.
Bio-Techne is a leading provider of specialized reagents, analytical instruments, and diagnostic solutions for the life sciences and clinical diagnostics sectors. The company leverages a diverse portfolio of proprietary brands and technologies to address complex needs in research and clinical applications. Its strong presence in both protein sciences and diagnostics enables it to serve a broad customer base and maintain a competitive position in the global biotechnology market.
Hollow Brook's decision to fully exit its Bio-Techne position is notable -- not just because of the size of the sale, but because a complete exit carries more weight than a partial sale. When a fund walks away entirely from a stock that was previously a 2.3% position in its portfolio, it can be worth investigating.
NASDAQ: TECH
TECH Trading
0.8% G/L:
$59.815 Last:
593,897 Volume:
$59.10 Open:
